These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26511069)

  • 1. Rational approach to an antiprion compound with a multiple mechanism of action.
    Bolognesi ML; Bongarzone S; Aulic S; Ai Tran HN; Prati F; Carloni P; Legname G
    Future Med Chem; 2015; 7(16):2113-20. PubMed ID: 26511069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variety of antiprion compounds discovered through an in silico screen based on cellular-form prion protein structure: Correlation between antiprion activity and binding affinity.
    Hosokawa-Muto J; Kamatari YO; Nakamura HK; Kuwata K
    Antimicrob Agents Chemother; 2009 Feb; 53(2):765-71. PubMed ID: 19015328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a class of diketopiperazines as antiprion compounds.
    Bolognesi ML; Ai Tran HN; Staderini M; Monaco A; López-Cobeñas A; Bongarzone S; Biarnés X; López-Alvarado P; Cabezas N; Caramelli M; Carloni P; Menéndez JC; Legname G
    ChemMedChem; 2010 Aug; 5(8):1324-34. PubMed ID: 20540064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palladium complexes affect the aggregation of human prion protein PrP106-126.
    Wang Y; Feng L; Zhang B; Wang X; Huang C; Li Y; Du W
    Inorg Chem; 2011 May; 50(10):4340-8. PubMed ID: 21504185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of NAMI-A-like ruthenium complexes on prion neuropeptide fibril formation.
    Wang X; Zhu D; Zhao C; He L; Du W
    Metallomics; 2015 May; 7(5):837-46. PubMed ID: 25856332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedure for identification and characterization of drugs efficient against mammalian prion: from a yeast-based antiprion drug screening assay to in vivo mouse models.
    Voisset C; Saupe SJ; Galons H; Blondel M
    Infect Disord Drug Targets; 2009 Feb; 9(1):31-9. PubMed ID: 19200013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiprion activity of functionalized 9-aminoacridines related to quinacrine.
    Nguyen TH; Lee CY; Teruya K; Ong WY; Doh-ura K; Go ML
    Bioorg Med Chem; 2008 Jul; 16(14):6737-46. PubMed ID: 18556207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiprion drugs as chemical tools to uncover mechanisms of prion propagation.
    Tribouillard D; Gug F; Galons H; Bach S; Saupe SJ; Blondel M
    Prion; 2007; 1(1):48-52. PubMed ID: 19164923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets.
    Bertsch U; Winklhofer KF; Hirschberger T; Bieschke J; Weber P; Hartl FU; Tavan P; Tatzelt J; Kretzschmar HA; Giese A
    J Virol; 2005 Jun; 79(12):7785-91. PubMed ID: 15919931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insight into the antiprion compound inhibition mechanism of native prion folding over misfolding.
    Choi J; Govindaraj RG; Hyeon JW; Lee K; Ma S; Kim SY; Lee J; No KT
    Chem Biol Drug Des; 2017 Jun; 89(6):907-917. PubMed ID: 27933736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiprion properties of prion protein-derived cell-penetrating peptides.
    Löfgren K; Wahlström A; Lundberg P; Langel U; Gräslund A; Bedecs K
    FASEB J; 2008 Jul; 22(7):2177-84. PubMed ID: 18296502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based drug design identifies polythiophenes as antiprion compounds.
    Herrmann US; Schütz AK; Shirani H; Huang D; Saban D; Nuvolone M; Li B; Ballmer B; Åslund AK; Mason JJ; Rushing E; Budka H; Nyström S; Hammarström P; Böckmann A; Caflisch A; Meier BH; Nilsson KP; Hornemann S; Aguzzi A
    Sci Transl Med; 2015 Aug; 7(299):299ra123. PubMed ID: 26246168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine for prion disease treatment: new insights into the role of dendrimers.
    McCarthy JM; Appelhans D; Tatzelt J; Rogers MS
    Prion; 2013; 7(3):198-202. PubMed ID: 23764833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion inhibition with multivalent PrPSc binding compounds.
    Mays CE; Joy S; Li L; Yu L; Genovesi S; West FG; Westaway D
    Biomaterials; 2012 Oct; 33(28):6808-22. PubMed ID: 22748770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New approaches for the selection and evaluation of anti-prion organic compounds.
    Cordeiro Y; Ferreira NC
    Mini Rev Med Chem; 2015; 15(2):84-92. PubMed ID: 25723455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of 2-aminothiazoles as potent antiprion compounds.
    Ghaemmaghami S; May BC; Renslo AR; Prusiner SB
    J Virol; 2010 Apr; 84(7):3408-12. PubMed ID: 20032192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship refinement and further assessment of indole-3-glyoxylamides as a lead series against prion disease.
    Thompson MJ; Louth JC; Ferrara S; Sorrell FJ; Irving BJ; Cochrane EJ; Meijer AJ; Chen B
    ChemMedChem; 2011 Jan; 6(1):115-30. PubMed ID: 21154498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of small molecules binding to the normal conformation of prion by combining virtual screening and multiple biological activity evaluation methods.
    Li L; Wei W; Jia WJ; Zhu Y; Zhang Y; Chen JH; Tian J; Liu H; He YX; Yao X
    J Comput Aided Mol Des; 2017 Dec; 31(12):1053-1062. PubMed ID: 29159521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovative Non-PrP-Targeted Drug Strategy Designed to Enhance Prion Clearance.
    Colini Baldeschi A; Zattoni M; Vanni S; Nikolic L; Ferracin C; La Sala G; Summa M; Bertorelli R; Bertozzi SM; Giachin G; Carloni P; Bolognesi ML; De Vivo M; Legname G
    J Med Chem; 2022 Jul; 65(13):8998-9010. PubMed ID: 35771181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.